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Abstract: In Palestine, as in other countries, brucellosis is an endemic disease, even in highly vaccinated zones. Many 
reports suggest that a decline in vaccine productivity may be due to antigenic shift s in the circulating Brucella melitensis. 
To address this aspect, the hemagglutinin gene from B. melitensis fi eld isolates was amplifi ed by polymerase chain 
reaction (PCR), sequenced, digested with the EcoRV and HaeIII, and compared to the Rev.1 strain of the B. melitensis 
vaccine. From January to December 2008, 80 milk samples were collected from infected fl ocks, from diff erent West 
Bank regions of Palestine. From these, 77.5% (62/80) were shown to be positive for specifi c B. melitensis PCR. However, 
from the PCR-positive milk samples, only 38 strains could be isolated by culture on Brucella agar plates. Th e nucleotide 
alignment and phylogenetic tree for the hemagglutinin gene showed a mismatch between the vaccine strain and fi eld 
isolates. Th is is also suggested by the observation of EcoRV and HaeIII digestion profi les for the vaccine strain and fi eld 
isolates. Although a limited number of isolates and genes encoding immunologically relevant proteins were analyzed, 
we observed antigenic divergence between the current B. melitensis fi eld isolates and the vaccine strain, in particular 
with respect to the hemagglutinin gene. Th erefore, more research will be necessary to rule out the possibility of reduced 
effi  cacy of Brucella whole-cell vaccines.
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Introduction
Brucellosis is a major zoonotic disease found all over 
the world. However, Brucella melitensis is particularly 
prevalent throughout the Mediterranean countries, 
parts of Africa, western Asia, and Latin America, 
aff ecting both animals and humans (1-10). Live 
attenuated vaccines such as B. melitensis strain Rev.1 
have been, and continue to be, essential elements in 
control programs.
A pilot vaccination program for small ruminants 
was initiated in 1998 in Palestine.
Despite vaccination, brucellosis is still been in 
the area (1,11). It is possible that vaccination might 
have initially reduced the circulation of B. melitensis 
and that adaptation allowed the B. melitensis 
population to restore its high circulation rate. Th is 
assumption predicts a change in the makeup of the 
B. melitensis population aft er the introduction of 
vaccination, a phenomenon that has indeed been 
observed elsewhere (12). Th erefore, we focused in 
the present study on the molecular characterization 
of B. melitensis strains circulating in the West Bank 
(Palestine) in comparison with the strain used in the 
vaccination.
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To address this aspect, the hemagglutinin gene 
from B. melitensis fi eld isolates was amplifi ed by 
polymerase chain reaction (PCR), sequenced, 
digested with EcoRV and HaeIII, and compared to a 
live-attenuated Rev.1 strain of B. melitensis vaccine.
Materials and methods
A total of 80 milk samples, collected from infected 
sheep and goat fl ocks from diff erent West Bank 
regions of Palestine, between January and December 
2008, were classifi ed as seropositive, based on a 
positive reaction to one or both of the rose Bengal 
test (RBT) and the complement fi xation test (CFT), 
according to Alton et al. (13).
Th e milk samples were inoculated onto Brucella 
agar plates (Oxoid Ltd. Hampshire, UK) in order 
to isolate Brucella spp., incubated at 37 °C in 10% 
CO2 for 5 to 10 days, and examined daily for the 
presence of colonies. Th e observed colonies were 
identifi ed as Brucella spp. by morphologic, cultural, 
and biochemical properties such as oxidase, H2S 
production, urease, and CO2 requirement (14). 
Sample processing for PCR
Genomic DNA was extracted from the milk 
samples using the Nucleospin tissue kit (Clonetech, 
Germany) according to the manufacturer’s 
instructions. PCR was performed in a 50 μL volume 
reaction mixture containing 10 mM tris-HCl 
(pH 8.4), 50 mM KCl, 1 mM MgCl2, 200 μM each 
deoxyribonucleotide triphosphate (dATP, dGTP, 
dTTP, and dCTP; Pharmacia LKB Biotechnology, 
Uppsala, Sweden), 0.5 U of Taq polymerase 
(Promega, Madison, WI, USA), and 10 nM of each 
primer (Syntezza, Israel). Th e primers (forward 
primer, 5’ AAATCGCGTCCTTGCTGGTCTGA; 
reverse primer, 5’ GACGATAGCGTTTCAACTTG) 
described by Bricker and Halling (15), were used to 
amplify a target sequence of 731-bp specifi c to IS711 
gene of B. melitensis. PCR was performed with a 
master cycler (BioRad Laboratories, Inc., Hercules, 
CA, USA) as follows: 30 cycles of PCR, with 1 cycle 
consisting of 120 s at 95 °C for DNA denaturation, 
45 s at 45 °C for DNA annealing, and 30 s at 72 °C 
for polymerase-mediated primer extension. Th e 
last cycle included incubation of the sample at 72 
°C for 6 min. Th e PCR products were resolved by 
electrophoresis on 2% agarose gel with ethidium 
bromide (0.5 mg/mL).
PCR and sequencing
Th e hemagglutinin gene from 2 of the B. melitensis 
fi eld isolates, 1/P and 2/P, was amplifi ed by PCR, 
sequenced, and compared to the Rev.1 strain of the 
B. melitensis vaccine. Th e primers (forward primer, 
5’GAACCAGAATACGGCAAAA; reverse primer, 
5’ GTCGTTTCTGCGTCAACAGA), were used for 
this purpose. Th ese primers were designed using 
Primer3 soft ware (http://frodo.wi.mit.edu/primer3) 
and synthesized by Syntezza. PCR was performed as 
described above and the products were analyzed by 
electrophoresis in 2% agarose gels. Th e PCR products 
were purifi ed using the MinElute PCR purifi cation kit 
(Qiagen, Germany) and the inserts were sequenced 
using a dideoxy chain termination method on an 
ABI PRISM Model 301 Sequence Instrument at 
Bethlehem University, Bethlehem, Palestine. Th e 
alignment of the DNA sequences, phylogenetic 
relationships, and restriction endonuclease digestion 
of the Brucella fi eld isolates and Rev.1 strain of B. 
melitensis vaccine were conducted using CLC Main 
Workbench soft ware; version 5.6.1, 2009. 
Th e nucleotide sequences of the 2 B. melitensis 
fi eld isolates (1/P and 2/P) from Palestine reported 
here have been submitted and assigned the GenBank 
accession number HM345998 and HM598409, 
respectively.
Results
Of the collected milk samples, 77.5% (62/80) were 
positive for specifi c B. melitensis PCR. However, from 
the PCR-positive milk samples, only 38 isolates could 
be cultured on Brucella agar plates.  
Polymorphism in the gene for hemagglutinin 
was studied in 2 fi eld isolates and the vaccine strain 
was studied by DNA sequencing. Version 5.6.1 
of the CLCL Main Workbench soft ware package 
was used for the alignment of DNA sequences, 
phylogenetic, and  EcoRV digestion relationships. 
Th e nucleotide alignment and phylogenetic tree for 
the hemagglutinin gene is shown in Figures 1 and 2. 
A remarked divergence was observed between the 
vaccine strain and the 2 fi eld isolates. We analyzed 
the EcoRV digestion profi les of the sequenced 
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- A - - AGGCAA AAACGGCC TG CAA T AAGCGG
- CC TGGCCAA AAAACGGC TG CGT C - - GCGG
T CC TGGGT CC AAAACGGC TG CGT C - - GCGG
CA - T ACC T T C GCGCGCCAGG GAGAACGTGA
CAA T ACC T T C GCGC - CGAGG GAAAACGTGA
CAA T ACCA T T - CGCGCCGAG GACAACGTGA
A TGA T AGT T C T AA T ACCC T T GAAGGAAAAC
A TGA T AGT T C T AA T ACCC T T GAAGGAAAAC
A TGA T AGT T C T AA T ACCC T T GAAGGGAAAA
TGT ACGGACG AC T A TGCGT C A T CAACGT TG
AGT - CGGACG AC T A TGCGT C A T CAACGT TG
CAGACGGACG AC T A TGCGT C A T CAACGT TG
GGT ACC T C T T CC T T AACC T T TGGGAC T CC T
GGT ACC T C T T CC T T AACC T T TGGGAC T CC T
GGT ACC T C T T CC T T AACC T T TGGGAC T CC T
T T CGGA T TGG AACC T CGGCA TGT AAC T CAG
T T CGGA T TGG AACC T CGGCA TGT AAC T CAG
T T CGGA T TGG AACC T CGGCA TGT AAC T CAG
GGGGCAA T CC TGGCAGAAAC GGCGCAGA T A
GGGGCAA T CC TGGCAGAAAC GGCGCAGA T A
GGGGCAA T CC TGGCAGAAAC GGCGCAGA T A
AACA T TGCAA CCGGCCA T AA GGCGACGGT T
AACA T TGCAA CCGGCCA T AA GGCGACGGT T
AACA T TGCAA CCGGCCA T AA GGCGACGGT T
T CCGAGGGCA T AA T AGGAAC CCAGAA T ACG
T CCGAGGGCA T AA T AGGAAC CCAGAA T ACG
T CCGAGGGCA T AA T AGGAAC CCAGAA T ACG
GCAAAACAAG AGGTGGCCGC T GGGGCAAGC
GCAAAACAAG AGGTGGCCGC T GGGGCAAGC
GCAAAACAAG AGGTGGCCGC T GGGGCAAGC
Figure 1. Partial nucleotide comparison between the hemagglutinin 
gene of 2 selected B. melitensis fi eld isolates and the vaccine 
strain of B. melitensis Rev.1. 
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fragment of the hemagglutinin gene obtained from 
the fi eld isolates and that obtained from the vaccine 
strain. As can be seen in Figure 3, EcoRV digestion 
was predicted to yield 2 DNA fragments. Th is was 
seen with the DNA from the fi eld isolates. However, 
the vaccine strain Rev.1 removed the cut site of the 
EcoRV, and so no fragment was generated by the 
EcoRV digestion (Figure 3). Th e HaeIII digestion of 
the amplifi ed fragments from the vaccine strain Rev.1 
yielded 3 DNA fragments. In contrast, no fragments 
were generated by HaeIII digestion from the fi eld 
isolates. 
Discussion
Th e Rev.1 vaccine is quite virulent and apparently 
unstable, creating the need for improved vaccines 
for B. melitensis (16). It is shown that vaccination can 
prevent abortion; however, it probably cannot provide 
complete protection against infection (15,17).
Here, we reported the fi rst study on B. melitensis 
molecular epidemiology in Palestine, showing a clear 
divergence between the strain used in vaccination 
and the fi eld isolates. Th e samples used in the present 
study were obtained from diff erent West Bank regions 
of Palestine, between January and December 2008. 
Of the total samples, 77.5% (62/80) proved to be B. 
melitensis by PCR, but only 47.5% (38 isolates) were 
culture positive. Th e low sensitivity of the culture 
method had already been reported (18,19). Th e 
higher sensitivity of the PCR assay can be explained 
by the fact that it detects DNA from bacteria that 
are damaged and/or dead; therefore, it may not be 
possible to isolate Brucella spp. by the conventional 
cultural techniques.
Despite the introduction of mass vaccination 
in 1998 in Palestine, brucellosis is currently an 
endemic disease with regular epidemic outbreaks. 
Th e nucleotide alignment and phylogenetic tree for 
the hemagglutinin gene showed a mismatch between 
the vaccine strain and fi eld isolates, suggesting that it 
may have played a role in driving the observed high 
prevalence of brucellosis. Th is is also confi rmed by 
the observation of a variation in EcoRV and HaeIII 
digest profi les for the vaccine strain and fi eld isolates. 
Although a limited number of isolates and 
genes encoding immunologically relevant proteins 
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Figure 2. A distance phylogenetic tree based on the partial nucleotide sequences 
of the hemagglutinin gene of 2 selected B. melitensis fi eld isolates (1/P 
and 2/P) and the vaccine strain of B. melitensis Rev.1. Th e tree was rooted 
using version 5.6.1 of the CLCL Main Workbench.
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Figure 3. Agarose gel electrophoresis of EcoRV and HaeIII 
digest of amplifi ed hemagglutinin gene fragments 
from 2 selected B. melitensis fi eld isolates (1/P and 2/P) 
and vaccine strain Rev.1; molecular size ladder in base 
pairs.
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were analyzed, we observed antigenic divergence 
between the current B. melitensis fi eld isolates and 
the vaccine strain, in particular with respect to the 
hemagglutinin gene. Th erefore, more research will 
be necessary to rule out the possibility of reduced 
effi  cacy of brucellosis whole-cell vaccines.
References
1. FAO/WHO/OIE.: Brucella melitensis in Eurasia and the Middle 
East. FAO Animal Production and Health Proceedings. No. 10. 
Rome, 2010.
2. Seleem, M.N., Boyle, S.M., Sriranganathan, N.: Brucellosis: a 
re-emerging zoonosis. Vet. Microbiol., 2010; 140: 392-398. 
3. Mantur, B.G., Amarnath, S.K., Shinde, R.S.: Review of clinical 
and laboratory features of human brucellosis. Indian J. Med. 
Microbiol., 2007; 25: 188-202. 
4. Gul, S.T., Khan, A.: Epidemiology and epizootology of 
brucellosis Pakistan Vet. J., 2007; 27: 145-151.
5. Cutler, S.J., Whatmore, A.M., Commander, N.J.: Brucellosis 
– new aspects of an old disease J. Appl. Microbiol., 2005; 98: 
1270-1281
6. Seimenis, A., Morelli, D., Mantovani, A.: Zoonoses in the 
Mediterranean region. Ann. Ist. Super. Sanita., 2006; 42: 437-45. 
7. Turkmani, A., Ioannidis, A., Christidou, A., Psaroulaki, A., 
Loukaides, F., Tselentis, Y.: In vitro susceptibilities of Brucella 
melitensis isolates to eleven antibiotics. Ann. Clin. Microbiol. 
Antimicrob., 2006; 2: 5-24
8. Maurin, M.: Brucellosis at the dawn of the 21st century. Med. 
Mal. Infect., 2005; 35: 6-16. 
9. Leyla, G., Kadri, G., Umran, O.: Comparison of polymerase 
chain reaction and bacteriological culture for the diagnosis of 
sheep brucellosis using aborted fetus samples. Vet. Microbiol., 
2003; 93: 53-61.
10. Refai, M.: Incidence and control of brucellosis in the Near East 
region. Vet. Microbiol., 2002; 90: 81-110.
11. Husseini, S., Ramlawi, A.M.: Brucellosis in the West Bank, 
Palestine. Saudi Med. J., 2004; 25: 1640-1643.
12. Bardenstein, S., Mandelboim, M., Ficht, T.A., Baum, M., Banai, 
M.: Identifi cation of the Brucella melitensis Vaccine strain Rev.1 
in animals and humans in Israel by PCR analysis of the PstI site 
polymorphism of its omp2 gene. J. Clin. Microbiol., 2002; 40: 
1475-1480.
13. Alton, G.G., Jones, L.M., Angus, R.D., Verger, J.M.: Techniques 
for the Brucellosis Laboratory. Institut National de la Recherche 
Agronomique Publications, 1988, Paris, France.
14. Quinn, P.J., Carter, M.E., Markey, B., Carter, G.R.: Brucella 
species. In: Clinical Veterinary Microbiology. P.J. Quinn, M.E. 
Carter, B.K. Markey, and G.R. Carter, Eds. Wolfe Publishing, 
London, UK, 1994, 261-267
15. Bricker, B.J., Halling, S.M.: Diff erentiation of Brucella abortus 
bv. 1, 2 & 4, Brucella melitensis, brucella ovis and Brucella suis 
bv. 1 by PCR. J. Clin. Microbiol., 1994; 32: 2660-2666.
16. Banai, M.: Control of small ruminant brucellosis by use of 
Brucella melitensis Rev.1 vaccine: laboratory aspects and fi eld 
observations. Vet. Microbiol., 2002; 90: 497-519.
17. Samartino, L.E., Fort, M., Gregoret, R., Schurig, G.: Use of 
Brucella abortus vaccine strain Rb51 in pregnant cows aft er calf 
hood vaccination with strain 19 in Argentina. Prev. Vet. Med., 
2000; 45: 193-9.
18. Bricker, B.J.: PCR as a diagnostic tool for brucellosis. Vet. 
Microbiol., 2002;  90: 435-420.
19. Hinić, V., Brodard, I., Th omann, A., Holub, M., Miserez, 
R., Abril, C.: IS711-based real-time PCR assay as a tool for 
detection of Brucella spp. in wild boars and comparison with 
bacterial isolation and serology. BMC Vet. Res., 2009; 5: 1-8.
